NCT05779787

Brief Summary

Whereas PCI before TAVR was previously recommended despite its uncertain prognostic role, recent data underline the possibility of a postponed coronary intervention using a commissural alignment technique. This approach allows easy coronary re-engagement through the valve stent frame with a trade off paid of procedure complexity. Considering the prevalence of coronary artery disease (CAD) and the increasing percentage of younger patients treated with TAVI, investigate whether a simpler procedure with random implantation of Navitor valve is not inferior in terms of coronary re-access, is required The key point of the project will be the evaluation of the feasibility of coronary re-engagement after a Navitor valve randomly implanted.

Trial Health

77
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
100

participants targeted

Target at P50-P75 for all trials

Timeline
10mo left

Started Feb 2023

Longer than P75 for all trials

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress82%
Feb 2023May 2027

Study Start

First participant enrolled

February 15, 2023

Completed
23 days until next milestone

First Submitted

Initial submission to the registry

March 10, 2023

Completed
12 days until next milestone

First Posted

Study publicly available on registry

March 22, 2023

Completed
3.9 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

February 15, 2027

Expected
3 months until next milestone

Study Completion

Last participant's last visit for all outcomes

May 15, 2027

Last Updated

April 16, 2026

Status Verified

April 1, 2026

Enrollment Period

4 years

First QC Date

March 10, 2023

Last Update Submit

April 13, 2026

Conditions

Outcome Measures

Primary Outcomes (1)

  • Coronary re-access after TAVR procedure

    Re-engagement of LMCA and RCA after valve implantation is defined as selective cannulation and subsequent selective angiography. All others type of re-engagement will be classify as "non selective". We will stratify also the modality of re-cannulation in relation to the position of the valves' stent struts as "above", "across" and "behind".

    During procedure

Secondary Outcomes (13)

  • Total Implant Time

    During procedure

  • Total Implant Fluoroscopy Time

    During procedure

  • Total Implant Radiations

    During procedure

  • Total Implant Contrast

    During procedure

  • Alignment Radiation

    During procedure

  • +8 more secondary outcomes

Study Arms (2)

TAVR performed with commissural alignment technique (Aligned Group)

Patients with severe aortic stenosis undergoing TAVR procedure performed with commissural alignment technique. We consider in this groups only the Accurate and Accurate Neo 2 Valve which are the first choice due to the best stent frames position predictability with this technique

Procedure: TAVR AlignedProcedure: TAVR Random

TAVR performed with random implantation of Navitor valve (Random Group)

Patients with severe aortic stenosis undergoing TAVR procedure performed with random implantation of Navitor Valve

Procedure: TAVR AlignedProcedure: TAVR Random

Interventions

TAVR AlignedPROCEDURE

Investigate the feasibility of coronary re-engagement after commissural alignment technique in terms of success rate (%) and procedure complexity taking into account radiations, time and contrast used.

TAVR performed with commissural alignment technique (Aligned Group)TAVR performed with random implantation of Navitor valve (Random Group)
TAVR RandomPROCEDURE

TAVR Random Feasibility comparison of coronary re-engagement between the randomly implanted Navitor valve (unaligned) and the others implanted with the commissural alignment technique in terms of success rate (%) and complexity of the procedure, taking into account radiation, time and contrast used

TAVR performed with commissural alignment technique (Aligned Group)TAVR performed with random implantation of Navitor valve (Random Group)

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Consecutive patients with severe aortic stenosis diagnosed according to ESC guidelines, undergoing transcatheters aortic valve replacement with Navitor valve randomly implanted or Acurate Neo with commisural alignment technique

You may not qualify if:

  • Patients excluded in this registry should have all the following criteria:
  • Valve in Valve procedure
  • Hemodynamical instability
  • TAVR performed from other access (not femoral)
  • No-CT Planned TAVR
  • TAVR performed with Chimney Technique

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

ASST GOM Niguarda

Milan, Lombardy, 20162, Italy

RECRUITING

MeSH Terms

Conditions

Aortic Valve Stenosis

Condition Hierarchy (Ancestors)

Aortic Valve DiseaseHeart Valve DiseasesHeart DiseasesCardiovascular DiseasesVentricular Outflow Obstruction

Central Study Contacts

Giuseooe Esposito, MD

CONTACT

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

March 10, 2023

First Posted

March 22, 2023

Study Start

February 15, 2023

Primary Completion (Estimated)

February 15, 2027

Study Completion (Estimated)

May 15, 2027

Last Updated

April 16, 2026

Record last verified: 2026-04

Locations